Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking method to diabetes management. These innovative therapies function by mimicking the physiological actions of GLP-1, a hormone produced by the https://explorebookmarks.com/story20693908/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes